COVID-19 Vaccine Contract Data

Fiocruz, AstraZeneca

Pfizer

AstraZeneca

CureVac

AstraZeneca - Leaked

AZD1222 Supply Agreement - [REDACTED] (1)

Sourced from KEI online

• Advanced Technology International (ATI) – Underlying contract to execute MCDC and COVID-19 contracts on behalf of the federal government.
  • DoD-ATI Other Transaction Authority Agreement W15QKN1691002-P00085. April 8, 2016.
  • DoD-ATI Other Transaction Authority Agreement W15QKN1691002-P00085. April 8, 2016. (Version obtained November 30, 2020 from HHS FOIA Reading Room)
• American Blood Center – convalescent plasma.
  • HHS/ASPR/BARDA-American Blood Center Contract 75A50120000094. April 17, 2020.
• AstraZeneca – vaccine.
  • HHS/ASPR/BARDA-AstraZeneca Advanced Agreement to Other Transaction Authority Agreement 75A501-20-C-00114. May 20, 2020.
  • HHS/ASPR/BARDA-AstraZeneca Modification of OTA Agreement 75A501-20-C-00114 MODP00001. July 31, 2020.
• AstraZeneca – vaccine.
  • DoD-AstraZeneca Other Transaction Authority Agreement W15QKN2191003. October 28, 2020.
• Biofire Defense – TECH.
  • DoD-Biofire Defense Supply Order W911QY13D0080-W911QY20F0271. April 24, 2020.
• Biofire Defense – TECH.
  • DoD-Biofire Defense Supply Order W911QY13D0080-W911QY20F0171. May 23, 2020.
• BCG Federal Corp – COVID-19-related support services.
  • DoD-BCG Federal Corp Contract W911QY20P0198. June 28, 2020.
• Cepheid – test kits.
  • DoD-Cepheid Contract W911QY20P0154. April 27, 2020.
• Corning Incorporated – vaccine manufacturing supplies.
  • DoD-Corning Contract W911NF2030004. June 5, 2020.
• Cue Health – diagnostics manufacturing supplies.
  • DoD-Cue Health Other Transaction Authority Agreement W911NF2190001. October 13, 2020.
• Cue Health – TECH.
  • HHS-Cue Health Contract HHSO100201800016C. June 4, 2018.
  • HHS-Cue Health Contract HHSO100201800016C Amendment P00003. May 13, 2020.
• Cytiva (Global Life Sciences Solutions) – vaccine manufacturing supplies.
  • DoD-Cytiva Contract W911NF2130001. October 13, 2020.
• Emergent Biosolutions – vaccine manufacturing.
  • HHS/ASPR/BARDA-Emergent Biosolutions Contract HHSO100201200004I. June 15, 2012.
  • HHS/ASPR/BARDA-Emergent Biosolutions Contract HHSO100201200004I -Task Order 75A50120F33007. May 24, 2020.
• Emory University – therapeutic.
  • DoD (via ATI)–Emory University Technical Direction Letter Other Transaction Authority W15QKN1691002. July 1, 2020.
• Genentech (Roche) -therapeutic.
  • HHS/ASPR/BARDA-Genentech Other Transaction Authority Agreement HHSO100201800036C. September 27, 2018.
  • HHS/ASPR/BARDA-Genentech Modification of OTA Agreement HHSO100201800036C. March 27, 2020.
• GlaxoSmithKline – vaccines.
  • DoD/ASPR/BARDA-GlaxoSmithKline Contract W15QKN20C0048. July 30, 2020.
    • DoD/ASPR/BARDA-GlaxoSmithKline Contract W15QKN20C0048-P00001. July 30, 2020.
    • DoD/ASPR/BARDA-GlaxoSmithKline Contract W15QKN20C0048-P00002. September 16, 2020
• Grifols Therapeutics – convalescent plasma.
  • DoD (via ATI)-Grifols Therapeutics Technical Direction Letter Other Transaction Authority Agreement W15QKN1691002. September 1, 2020.
• Grand River Aseptic Manufacturing (GRAM) – vaccine and therapeutic manufacturing.
  • DoD-Grand River Aseptic Manufacturing (GRAM) Contract W3110Y2OCC086R1033. August 4, 2020.
• Inovio Pharmaceuticals – vaccine delivery.
  • DoD-Inovio Pharmaceuticals Contract W911QY20C0084. June 18, 2020. (Version obtained from SEC filings)
  • DoD-Inovio Pharmaceuticals Contract W911QY20C0084. June 18, 2020. (Version obtained via FOIA request)
  • DoD-Inovio Pharmaceuticals Other Transaction Authority Agreement W911QY2090016. June 22, 2020.
• Johnson&Johnson (Janssen) – vaccine.
  • HHS/ASPR/BARDA-Janssen Other Transaction Authority Agreement HHSO100201700018C (Version obtained by FOIA March 31, 2021).
  • HHS/ASPR/BARDA-Janssen Amendment to OTA Agreement HHSO100201700018C-Amendment 6. February 11, 2020.
  • HHS/ASPR/BARDA-Janssen Amendment to OTA Agreement HHSO100201700018C-Amendment 6. February 11, 2020. (Version obtained by FOIA March 31, 2021).
  • HHS/ASPR/BARDA-Janssen Amendment to OTA Agreement HHSO100201700018C-Amendment 7. March 20, 2020.
  • HHS/ASPR/BARDA-Janssen Amendment to OTA Agreement HHSO100201700018C-Amendment 8. March 27, 2020.
  • HHS/ASPR/BARDA-Janssen Amendment to OTA Agreement HHSO100201700018C-Amendment 8. February 11, 2020. (Version obtained by FOIA March 31, 2021).
• Johnson&Johnson (Janssen) – therapeutic.
  • HHS/ASPR/BARDA-Janssen Other Transaction Authority Agreement HHSO100201800012C. September 21, 2018.
  • HHS/ASPR/BARDA-Janssen Amendment to OTA Agreement HHSO100201800012C-Amendment 4. February 14, 2020.
• Johnson&Johnson (Janssen) – vaccine.
  • DoD (via ATI)-Janssen Other Transaction Authority Agreement W15QKN1691002-P00081. August 5, 2020.
• Merck Sharp & Dohme – vaccine.
  • (Note: HHSO100201600031C began as a contract to Bioprotection Systems for an Ebola vaccine, Merck entered into a collaboration agreement with BPS in 2014)
  • HHS/ASPR/BARDA–Bioprotection Systems Corporation Contract HHSO100201600031C. September 29, 2016.
  • HHS/ASPR/BARDA–Bioprotection Systems Corporation Contract HHSO100201600031C-Attachment 2-Milestones. May 19, 2017.
  • HHS/ASPR/BARDA–Bioprotection Systems Corporation Contract HHSO100201600031C-Attachment 1-Statement of Work. May 19, 2017.
  • HHS/ASPR/BARDA–Bioprotection Systems Corporation Contract HHSO100201600031C-P00001. April 27, 2017.
  • HHS/ASPR/BARDA–Bioprotection Systems Corporation Contract HHSO100201600031C-P00002. September 6, 2017.
  • HHS/ASPR/BARDA–Bioprotection Systems Corporation Contract HHSO100201600031C-P00003. May 23, 2018.
  • HHS/ASPR/BARDA-Merck Sharp & Dohme Contract Amendment HHSO100201600031C-P00004. May 9, 2019.
  • HHS/ASPR/BARDA-Merck Sharp & Dohme Contract Amendment HHSO100201600031C-P00005. April 14, 2020. (Version obtained March 2021 via FOIA lawsuit)
  • HHS/ASPR/BARDA-Merck Sharp & Dohme Contract Amendment HHSO100201600031C-P00005. April 14, 2020.
• Merck Sharp & Dohme – therapeutic.
  • DoD-Merck Sharp & Dohme Other Transaction Authority Agreement W911QY2190001. December 2, 2020.
• Moderna – vaccine.
  • HHS/ASPR/BARDA-Moderna Contract 75A50120C00034. April 16, 2020.
  • HHS/ASPR/BARDA-Moderna Contract 75A50120C00034. April 16, 2020. (Less redacted version obtained via FOIA lawsuit on February 8, 2021)
• Moderna – vaccine manufacturing.
  • DoD/ASPR/BARDA-Moderna Contract W911QY20C0100. August 9, 2020. (Version obtained from Moderna SEC filings)
  • DoD/ASPR/BARDA-Moderna Contract W911QY20C0100. August 9, 2020. (Version obtained October 29, 2020 from HHS FOIA Reading Room)
  • DoD/ASPR/BARDA-Moderna Contract W911QY20C0100. August 9, 2020. (Version obtained November 9, 2020 from HHS FOIA Reading Room)
    • DoD/ASPR/BARDA-Moderna Contract W911QY20C0100-P00001. August 9, 2020.
    • DoD/ASPR/BARDA-Moderna Contract W911QY20C0100-P00002. September 11, 2020.
    • DoD/ASPR/BARDA-Moderna Contract W911QY20C0100-P00003. December 11, 2020.
• New Horizons Diagnostics Corp. – diagnostic.
  • DOD (via ATI)-New Horizons Diagnostics Technical Direction Letter Other Transaction Authority Agreement W15QKN1691002. May 26, 2020.
• Novavax – vaccine.
  • DoD-Novavax Contract W911QY20C0077. June 4, 2020.
• Novavax – vaccine.
  • DoD (via ATI)-Novavax Other Transaction Authority Agreement W15QKN1691002. June 25, 2020.
  • DoD (via ATI)-Novavax Technical Direction Letter W15QKN1691002. July 6, 2020. (Version obtained November 30, 2020 from HHS FOIA Reading Room)
• Ology Bioservices (previously called Nanotherapeutics, Inc.) – vaccine manufacturing.
  • DoD-Ology Bioservices Other Transaction Authority Agreement OTA-W911QY2090003. February 21, 2020.
  • DoD-Ology Bioservices Other Transaction Authority Agreement Appendix OTA-W911QY2090003-Appendix-A-4. March 20, 2020.
  • DoD-Ology Bioservices Contract W911QY2090003-MOD-P00005. March 22, 2020.
• Ology Bioservices (previously called Nanotherapeutics, Inc.) – TECH.
  • DoD-Ology Bioservices Contract W911QY20C0101. August 17, 2020.
• Oxford Nanopore Technologies – TECH.
  • DoD-Oxford Nanopore Technologies Contract W911QX20P0073. April 22, 2020.
• Partner Therapeutics, Inc. – therapeutic.
  • DOD (via ATI)-Partner Therapeutics Technical Direction Letter OTA W15QKN1691002. August 13, 2020.
• Patricio Enterprises – COVID-19 mobile lab staffing.
  • DoD-Patricio Enterprises Contract W911QY18D0251. June 3, 2020.
• Pfizer – vaccine.
  • DoD (via ATI)-Pfizer Technical Direction Letter OTA W15QKN1691002. July 21, 2020.
• Phlow Corporation – therapeutic.
  • HHS/ASPR/BARDA-Phlow Corporation Contract 75A50120000092. May 18, 2020.
• Protein Sciences Corporation (Sanofi) – vaccine.
  • HHS-ASPR/BARDA-Protein Sciences Corp Contract HHSO100201600005I. February 14, 2020.
• Regeneron Pharmaceuticals – therapeutic.
  • HHS/ASPR/BARDA-Regeneron Other Transaction Authority Agreement HHSO100201700020C. September 21, 2017.
  • HHS/ASPR/BARDA-Regeneron Other Transaction Authority Agreement HHSO100201700020C-MOD(redacted). January 31, 2020.
  • HHS/ASPR/BARDA-Regeneron Other Transaction Authority Agreement HHSO100201700020C-MOD0006. (Date redacted).
• Regeneron – therapeutic manufacturing.
  • DoD (via ATI)-Regeneron Other Transaction Authority Agreement W15QKN1691002. July 6, 2020.
  • DoD (via ATI–Regeneron Technical Direction Letter W15QKN1691002. July 6, 2020. (Version obtained November 30, 2020 from HHS FOIA Reading Room)
• Rigel Pharmaceuticals – therapeutic.
  • DOD-Rigel Pharmaceuticals Other Transaction Authority Agreement W911QY2190018. January 29, 2021.
• Sanofi – vaccine. 
  • DOD (via ATI)-Sanofi Technical Direction Letter W15QKN1691002. July 30, 2020. (Version obtained November 30, 2020 from HHS FOIA Reading Room)
• SourceAmerica – face coverings.
  • DoD-SourceAmerica Contract W911QY20C0047. April 17, 2020.
• Tasso – antibody test kits.
  • DoD-Tasso Serology Contract W911QY20P0158. May 1, 2020. (Version obtained November 30, 2020 from HHS FOIA Reading Room)
• Ultran Group – treatment device.
  • DOD (via ATI)–Ultran Group Technical Direction Letter Other Transaction Authority Agreement W15QKN1691002. September 16, 2020.
• Vyaire Medical, Inc. – ventilators.
  • HHS/ASPR/SNS-Vyaire Medical Contract 75A50120000049. March 31, 2020.
• 98Point6 – COVID-related Smartphone technology.
  • HHS-98Point6 Contract 75A50120C001519. October 9, 2020.

The searching scripts can be found here